文献速递心力衰竭与心肌病冠心病血脂与心血管预防

Look AHEAD 试验:2型糖尿病身体成分基线及纵向变化与心衰和心梗风险的关联

Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial.
PubMed 文献 · Circulation · 2020-11-09

本研究基于 Look AHEAD 试验中 5103 例无 prevalent HF 的 2 型糖尿病成人,随访 12.4 年发生 257 例心衰事件。基线身体成分与心衰风险无显著关联,而 1 年内脂肪质量(FM)和腰围(WC)下降而非瘦质量(LM)下降与整体心衰风险降低显著相关,且 WC 下降仅与射血分数保留的心衰(HFpEF)风险降低相关,身体成分变化与心梗风险无显著关联。

要点

  • 基线 FM、LM、WC 与心衰风险无显著关联。
  • 1 年 FM 和 WC 下降与整体心衰风险降低显著相关,LM 下降无此关联。
  • WC 下降仅与 HFpEF 风险降低相关,与 HFrEF 无关;身体成分变化与心梗风险无关。

核心结论

  • 在 2 型糖尿病成人中,生活方式干预带来 FM 和 LM 显著减少;FM 和 WC 下降而非 LM 下降与心衰风险降低显著相关,但与心梗风险无关;WC 下降仅与 HFpEF 风险降低显著相关。

研究设计与样本

  • Look AHEAD 试验的事后分析,纳入无 prevalent HF 的 2 型糖尿病成人 5103 例,随访 12.4 年。
  • FM 和 LM 通过经验证方程预测,并在亚组(n=1369)中与双能 X 线吸收法测量比对(R²=0.87-0.90)。
  • 采用校正 Cox 模型评估基线及 1 年和 4 年纵向变化的 FM、LM、WC 与整体 HF、HFpEF(EF≥50%)、HFrEF(EF<50%)及 MI 风险的关联。

主要发现

  • 随访 12.4 年共发生 257 例 incident HF 事件。
  • 基线身体成分指标与 HF 风险无显著关联。
  • 1 年内 FM 每下降 10%,整体 HF 风险校正 HR 为 0.80(95% CI 0.68-0.95);WC 每下降 10%,校正 HR 为 0.77(95% CI 0.62-0.95)。
  • FM 下降与两种 HF 亚型风险降低均显著相关;WC 下降与 HFpEF 风险降低显著相关,与 HFrEF 无显著关联。
  • 4 年身体成分变化与 HF 风险的关联模式与 1 年变化类似;身体成分纵向变化与 MI 风险无显著关联。

临床怎么用

  • 在 2 型糖尿病患者的体重管理中,关注脂肪质量和腰围的下降可能有助于降低心衰风险,尤其是 HFpEF。
  • 瘦质量下降与心衰风险降低无关,提示减重干预应注重脂肪减少而非单纯体重下降。
  • 身体成分改善与心梗风险无显著关联,冠心病预防需综合其他危险因素管理。

局限性

  • FM 和 LM 主要通过预测方程估算,仅在亚组中与 DXA 测量比对。
  • 研究为观察性分析,不能确立因果关系。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intentional weight loss is associated with lower risk of heart failure (HF) and atherosclerotic cardiovascular disease among patients with type 2 diabetes. However, the contribution of baseline measures and longitudinal changes in fat mass (FM), lean mass (LM), and waist circumference (WC) to the risk of HF and myocardial infarction (MI) in type 2 diabetes is not well established. METHODS: Adults from the Look AHEAD trial (Action for Health in Diabetes) without prevalent HF were included. FM and LM were predicted using validated equations and compared with dual-energy x-ray absorptiometry measurements in a subgroup. Adjusted Cox models were used to evaluate the associations of baseline and longitudinal changes in FM, LM, and WC over 1- and 4-year follow-up with risk of overall HF, HF with preserved ejection fraction (EF; EF ≥50%), HF with reduced EF (EF <50%), and MI. RESULTS: Among 5103 participants, there were 257 incident HF events over 12.4 years of follow-up. Predicted and measured FM/LM were highly correlated (R2=0.87-0.90; n=1369). FM and LM decreased over 4-year follow-up with greater declines in the intensive lifestyle intervention arm. In adjusted analysis, baseline body composition measures were not significantly associated with HF risk. Decline in FM and WC, but not LM, over 1 year were each significantly associated with lower risk of overall HF (adjusted hazard ratio per 10% decrease in FM, 0.80 [95% CI, 0.68-0.95]; adjusted hazard ratio per 10% decrease in WC, 0.77 [95% CI, 0.62-0.95]). Decline in FM was significantly associated with lower risk of both HF subtypes. In contrast, decline in WC was significantly associated with lower risk of HF with preserved EF but not HF with reduced EF. Similar patterns of association were observed for 4-year changes in body composition and HF risk. Longitudinal changes in body composition were not significantly associated with risk of MI. CONCLUSIONS: In adults with type 2 diabetes, a lifestyle intervention is associated with significant loss of FM and LM. Declines in FM and WC, but not LM, were each significantly associated with lower risk of HF but not MI. Furthermore, decline in WC was significantly associated with lower risk of HF with preserved EF but not HF with reduced EF. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00017953.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Patel KV, Bahnson JL, Gaussoin SA, et al. Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial. Circulation. 2020. PMID: 33164570. doi:10.1161/CIRCULATIONAHA.120.050941

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。